Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study
- PMID: 29499055
- PMCID: PMC5834174
- DOI: 10.1371/journal.pone.0193646
Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study
Abstract
Helicobacter pylori is a gastrointestinal pathogen known to be associated with cardiovascular disease (CVD). However, most analyses about the effect of H. pylori infection have been done in patients with a history of CVD but not in healthy subjects. We evaluated the association between H. pylori infection and subclinical atherosclerosis by using cardiac multidetector computed tomography (MDCT) in healthy subjects without previous CVD. From December 2007 to February 2014, 463 subjects who underwent the rapid urease test (CLO test), pulse-wave velocity (PWV) measurement, and MDCT for a self-referred health check-up were enrolled to this study. Helicobacter pylori infection was defined on the basis of CLO test positivity on endoscopic gastric biopsy. Significant coronary artery stenosis was defined as ≥50% stenosis in any of the major epicardial coronary vessel on MDCT. The CLO-positive subjects had a lower high-density lipoprotein-cholesterol (HDL-cholesterol) level compared to the CLO-negative subjects. The incidence of significant coronary stenosis was higher in the CLO-positive group (7.6% vs. 2.9%, P = 0.01). Furthermore, the number of subjects with coronary artery calcium score >0 and log{(number of segments with plaque)+1} were also significantly higher in the CLO-positive group. However, there was no statistical difference in the number of subjects with coronary artery calcium score >100, the prevalence of any plaque nor the plaque characteristics (calcified, mixed, or soft). Pulse-wave velocity (PWV) was neither associated with CLO test positivity. The CLO-positive group was 3-fold more likely to have significant coronary artery stenosis even after adjusting for confounding factors (adjusted odds ratio 2.813, 95% confidence interval 1.051-7.528, P = 0.04). In a healthy population, current H. pylori infection was associated with subclinical but significant coronary artery stenosis. The causal relationship between H. pylori infection and subclinical atherosclerosis in a "healthy" population remains to be investigated in the future.
Conflict of interest statement
Figures


Model 1: Not adjusted
Model 2: adjusted for age and sex
Model 3: adjusted for age, sex, HDL-cholesterol
Model 4: adjusted for age, sex, systolic BP, fasting glucose, HDL-cholesterol, anti-hypertension medication, anti-diabetic medication, lipid lowering agent, anti-platelet agent
Similar articles
-
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31. J Physiol Pharmacol. 2001. PMID: 11795863 Clinical Trial.
-
Endoscopic tests for the diagnosis of Helicobacter pylori infection in children: Validation of rapid urease test.Helicobacter. 2010 Jun;15(3):227-32. doi: 10.1111/j.1523-5378.2010.00756.x. Helicobacter. 2010. PMID: 20557365
-
Normal-weight obesity is associated with increased risk of subclinical atherosclerosis.Cardiovasc Diabetol. 2015 May 21;14:58. doi: 10.1186/s12933-015-0220-5. Cardiovasc Diabetol. 2015. PMID: 25990248 Free PMC article.
-
Helicobacter pylori infection and the progression of atherosclerosis: A systematic review and meta-analysis.Helicobacter. 2022 Feb;27(1):e12865. doi: 10.1111/hel.12865. Epub 2021 Nov 28. Helicobacter. 2022. PMID: 34841620 Review.
-
Helicobacter pylori infection and atherosclerosis: is there a causal relationship?Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2293-2301. doi: 10.1007/s10096-017-3054-0. Epub 2017 Jul 27. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28752210 Review.
Cited by
-
Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis.Biomed Res Int. 2022 Oct 22;2022:9943158. doi: 10.1155/2022/9943158. eCollection 2022. Biomed Res Int. 2022. PMID: 36317116 Free PMC article. Review.
-
Teaching an old dog new tricks: The prognostic role of CACS in hospitalized COVID-19 patients.Atherosclerosis. 2021 Jul;328:106-107. doi: 10.1016/j.atherosclerosis.2021.05.015. Epub 2021 May 27. Atherosclerosis. 2021. PMID: 34074488 Free PMC article. No abstract available.
-
Helicobacter pylori and its association with autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis and Sjögren syndrome.J Transl Autoimmun. 2021 Nov 14;4:100135. doi: 10.1016/j.jtauto.2021.100135. eCollection 2021. J Transl Autoimmun. 2021. PMID: 34825158 Free PMC article.
-
Assessing the Impact of Helicobacter pylori Infection and Inflammatory Bowel Disease on Pulse Wave Velocity and Arterial Stiffness.Cureus. 2021 May 10;13(5):e14944. doi: 10.7759/cureus.14944. Cureus. 2021. PMID: 34123641 Free PMC article. Review.
-
Anti-Glycan Autoantibodies Induced by Helicobacter pylori as a Potential Risk Factor for Myocardial Infarction.Front Immunol. 2020 Apr 8;11:597. doi: 10.3389/fimmu.2020.00597. eCollection 2020. Front Immunol. 2020. PMID: 32322255 Free PMC article.
References
-
- Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100: e20–28. - PubMed
-
- Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E, Oguma K. Chronic infections and atherosclerosis. Ann N Y Acad Sci. 2007;1108: 594–602. - PubMed
-
- Coskun S, Kasirga E, Yilmaz O, Bayindir P, Akil I, Yuksel H, et al. Is Helicobacter pylori related to endothelial dysfunction during childhood? Pediatr Int. 2008;50: 150–153. doi: 10.1111/j.1442-200X.2008.02542.x - DOI - PubMed
-
- Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345: 196–202. doi: 10.1016/j.canlet.2013.08.016 - DOI - PubMed
-
- Yamaoka Y, Graham DY. Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014;10: 1487–1500. doi: 10.2217/fon.14.29 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical